The Klingenstein Third Generation Foundation
7
1
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Genetic and Neural Predictors of Adolescent Depression
Role: collaborator
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
Role: collaborator
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
Role: collaborator
Shaping Actions and Responses to Emotions
Role: collaborator
Predictors of Response to Treatment for Depression
Role: collaborator
Promoting Treatment Access Following Pediatric Primary Care Depression Screening
Role: collaborator
Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
Role: collaborator
All 7 trials loaded